Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Analyst picks & changes

Alpha-Beta Technology Inc.

(ABTI)

Gregory Brown of Vector Securities International upgraded ABTI to "buy." Brown had lowered

Read the full 179 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE